STAT

APRIL 19, 2023

For many years, there’s been considerable debate about the best age for women to initiate breast cancer screening.The U.S. Preventive Services Task Force recommends that women start getting screenings around age 50, while groups such as the American Cancer Society recommend screenings begin at an earlier age. Now a large new study suggests that if Black women begin screening for breast cancer at age 42, that could help lower racial disparities in breast cancer deaths.

346

346

PharmaVoice

APRIL 19, 2023

One of the country’s leading burnout experts explains how companies can help keep high stress from becoming a high desire to leave the job.

246

246

STAT

APRIL 19, 2023

University of Michigan pediatric neurologist Vivian Cheung made a name for herself studying rare genetic diseases, and in 2008 — when she was on the faculty at the University of Pennsylvania — was hired as a Howard Hughes Medical Institute investigator, an honor for which she received $1 million a year over the next 12 years to further her research.

317

317

PharmaVoice

APRIL 19, 2023

A chemical engineer by training, Brii’s chief technology officer is applying her experience to solve research problems from the clinic to commercial development.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

APRIL 19, 2023

An expert panel that advises the Centers for Disease Control and Prevention on vaccination policy informally endorsed a plan Wednesday to offer an additional Covid-19 booster shot to people 65 and older as well as people who are immunocompromised, and to simplify the Covid vaccine schedule. The Advisory Committee on Immunization Practices was not asked to vote on the changes , announced Tuesday by the Food and Drug Administration.

Vaccines 259

Vaccines Immunity Immunization 259

BioPharma Dive

APRIL 19, 2023

A study abstract inadvertently posted online showed J&J and Legend’s therapy, Carvykti, reduced the risk of disease progression or death by more than 70% over standard drugs.

120

120

European Pharmaceutical Review

APRIL 19, 2023

“The approval of Omisirge is a significant development in hematopoietic stem cell transplantation” Omisirge ® (omidubicel-onlv), now US Food and Drug Administration (FDA) approved , is the first allogeneic stem cell transplant therapy to be given marketing authorisation based on results from a global, randomised Phase III clinical study. The treatment is indicated for patients 12 years and older with hematologic malignancies planned for umbilical cord blood transplantation, following myeloablati

111

111

STAT

APRIL 19, 2023

The U.S. Supreme Court on Wednesday extended a stay on limits to a federally approved abortion drug, giving the panel two more days to consider a case that could determine whether the widely used medication can remain on the market. The stay, now in place until the end of Friday, was due to end at midnight amid an unprecedented case testing the Food and Drug Administration’s authority to approve and regulate drugs.

246

246

The Pharmacist

APRIL 19, 2023

Community pharmacies have prevented 600 future heart attacks and strokes in the first year of the NHS Community Pharmacy Blood Pressure Check Service, the Company Chemists’ Association (CCA) has estimated. It suggested that with adequate investment, community pharmacy could become a ‘one-stop-shop’ for initial cardiovascular care where appropriate and free up much-needed capacity in GP […] The post Community pharmacy prevented 600 heart attacks and strokes in a year, says CCA appeared firs

Community Pharmacies 88

Community Pharmacies 88

STAT

APRIL 19, 2023

Just one week after the season finale of the HBO show “The Last of Us,” about a zombie apocalypse caused by a fungal infection, the Centers for Disease Control and Prevention issued a warning about Candida auris spreading in U.S. health care facilities. Twenty-seven states and Washington, D.C. have reported cases of the deadly fungal infection that often doesn’t respond to common antifungal drugs, with southern Nevada emerging as a hotspot of infections.

Immunity 213

Immunity Immunization 213

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Med Ed 101

APRIL 19, 2023

Beta-blockers are a class of medication that is frequently used for cardiac and cardiovascular purposes. Selectivity and evidence of benefit often guide selection, but one thing that may get overlooked is beta-blocker interactions in relation to CYP enzymes. Not all beta-blockers interact with CYP enzymes and those that don’t always follow a pattern.

97

97

STAT

APRIL 19, 2023

The calamity of March 2020 arrived two years later for pediatric units. In the fall of 2022, a tidal wave of respiratory viral illnesses sent children to emergency rooms in droves when enterovirus, respiratory syncytial virus (RSV), and influenza peaked in close succession, bombarding young children who had remained mostly unexposed to these viruses during the most acute years of the Covid pandemic.

Vaccines 188

Vaccines Hospitals 188

Pharmaceutical Technology

APRIL 19, 2023

GSK has signed an agreement to buy Canadian late-stage biopharmaceutical company BELLUS Health for $2bn (£1.6bn). GSK will buy all the outstanding shares in BELLUS for $14.75 per share in cash. GSK expects that the BELLUS Health acquisition will boost its speciality medicines and respiratory pipeline. The company will gain access to BELLUS’s investigational, twice-daily oral P2X3 receptor antagonist, camlipixant, to treat refractory chronic cough (RCC).

97

97

Drug Patent Watch

APRIL 19, 2023

This article was originally published by Jiayi Chen, Zhifeng Zhao, Xinyu Wang and Jingjun Huang in Drug Repurposing – Advances, Scopes and Opportunities in Drug Discovery and is republished here… The post Utilizing 505(b)(2) Regulatory Pathway for New Drug Applications: An Overview on the Advanced Formulation Approach and Challenges appeared first on DrugPatentWatch - Make Better Decisions.

96

96

The Pharmacist

APRIL 19, 2023

The British Medical Association (BMA) has declared its disappointment that the HRT pre-payment certificate (PPC) was launched before GP computer systems were updated to automate separate prescriptions for HRT and other items. In a bulletin sent on behalf of its GP Committee in England (GPCE), the BMA said that 'GPCE supports the government’s decision to […] The post GPs 'disappointed' that HRT PPC launched without automated separate prescriptions appeared first on The Pharmacist.

80

80

Pharma Times

APRIL 19, 2023

Link-up has already delivered data showing the promise of nanoparticle-formulated doggybone DNA

Vaccines 119

Vaccines 119

Express Pharma

APRIL 19, 2023

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Roflumilast Tablets, 250 mcg (USRLD: Daliresp Tablets, 250 mcg). Roflumilast reduces inflammation in the lungs which leads to chronic obstructive pulmonary disease (COPD). It is used to prevent the worsening of symptoms in people with severe COPD.

90

90

Pharma Times

APRIL 19, 2023

Effective treatment of AID is still a considerable area of unmet medical requirements

111

111

cureatr

APRIL 19, 2023

Hospital leaders have a clinical — and fiduciary — duty to better manage care transitions to avoid readmissions. Excessive readmissions aren't just risks to patient safety and the organization's reputation. Under current structures for Medicare penalties, excessive 30-day readmission rates can significantly threaten a hospital's bottom line.

Hospitals 77

Hospitals 77

European Pharmaceutical Review

APRIL 19, 2023

A market report has identified that global demand for electronic smart packaging will reach $2.6 billion in 2033. This represents a compound annual growth rate (CAGR) of 15.4 percent from 2023, according to the data. Smart packaging has potential for the integration of electronic functionality, enabling compliance, material identification, condition monitoring and asset tracking of pharmaceutical products.

Packaging 77

Packaging Labelling Compounding 77

World Pharma News

APRIL 19, 2023

GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, late-stage biopharmaceutical company working to better the lives of patients suffering from refractory chronic cough (RCC) for US$14.75 per share of common stock in cash representing an approximate total equity value of US$2.0 billion (£1.6 billion).

70

70

PhRMA

APRIL 19, 2023

PhRMA has awarded a $140,000 grant to the Emerson Diversity Health Foundation as part of our commitment to addressing health inequities and enhancing clinical trial diversity.

69

69

BioPharma Dive

APRIL 19, 2023

Forbion and Gilde Healthcare raised a combined $2 billion across their respective funds to invest in emerging biotech and life sciences companies.

70

70

Pharmacy Joe

APRIL 19, 2023

In this episode, I’ll discuss the use of sugammadex in myasthenia gravis patients undergoing thymectomy. Episode 810: Sugammadex To Reduce Postoperative Myasthenic Crisis After Thymectomy Subscribe on iTunes , Android , or Stitcher A group of authors in Japan recently analyzed the association between the use of sugammadex and postoperative myasthenic crisis in patients with myasthenia gravis using a national inpatient database. 506 patients who received sugammadex were compared with 289 controls

Inpatient 59

Inpatient Hospitals 59

BioPharma Dive

APRIL 19, 2023

An administrative stay of a Texas district court ruling will remain in place through Friday, pushing out a Supreme Court decision in the closely watched case over the drug mifepristone.

62

62

FDA Law Blog: Biosimilars

APRIL 19, 2023

By Deborah L. Livornese — Last week FDA checked off another item on its to-do list for implementing the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) OTC monograph reform provisions. As provided in the OMUFA Performance Goals letter , FDA issued draft guidance on the content and format of submissions. The draft guidance for industry entitled Over-the-Counter Monograph Order Requests (OMORs): Format and Content , outlines the information (content) and the form of and manner in

Documentation 59

Documentation Labelling 59

PhRMA

APRIL 19, 2023

PhRMA ha otorgado una beca de 140.000 USD a la “ Emerson Diversity Health Foundation ” como parte de nuestro compromiso de enfrentar la desigualdad en la asistencia médica y aumentar la diversidad de los elegidos para ensayos clínicos.

59

59

Pharmafile

APRIL 19, 2023

ANGLE, a liquid biopsy company, and BioView, a company developing, manufacturing and marketing automated microscopy imaging and analysis solutions, have announced a partnership to develop a liquid biopsy circulating tumour cell (CTC) HER2 assay for breast cancer. The partnership will leverage ANGLE’s FDA-approved Parsortix PC1 Clinical System to harvest CTCs and BioView’s automated microscopy systems and software to detect and assess the HER2 expression and/or gene amplification in CTCs through

Communication 58

Communication 58

Express Pharma

APRIL 19, 2023

The new $25 million center will be an advanced training and collaboration hub for pharma and nutraceutical manufacturers around the world Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical and nutraceutical excipients has announced the grand opening of its new pharma innovation center, located near Philadelphia, Pennsylvania, right in the heart of the United States’ Northeastern pharmaceutical corridor.

Dosage 52

Dosage Drug Development 52

Drug Patent Watch

APRIL 19, 2023

Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. It is available from one supplier. There are forty-six… The post New patent for Amicus Therap drug GALAFOLD appeared first on DrugPatentWatch - Make Better Decisions.

52

52

National Association of Boards of Pharmacy

APRIL 19, 2023

As the DSCSA interoperability deadline approaches, we at NABP remain focused on critical Drug Supply Chain Security Act (DSCSA) infrastructure and committed to helping align all sectors of the supply chain that support and provide safe medication to patients in the United States. This is the first blog of a series that explores steps we must take before the November DSCSA deadline.

52

52

Drug Patent Watch

APRIL 19, 2023

Annual Drug Patent Expirations for DHIVY Dhivy is a drug marketed by Avion Pharms and is included in one NDA. It is available from one supplier. There is one patent… The post New patent for Avion Pharms drug DHIVY appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharmaceutical Business Review

APRIL 19, 2023

A first-in-class, phosphate absorption inhibitor, Xphozah will be used to control serum phosphate in adults with chronic kidney disease (CKD) on dialysis and who had an insufficient response or intolerance to a phosphate binder therapy. It has a new action mechanism and acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3). This reduces the absorption of phosphate via the paracellular pathway, which is the main pathway of phosphate absorption.

Labelling 52

Labelling 52

Drug Patent Watch

APRIL 19, 2023

Annual Drug Patent Expirations for EMERPHED Emerphed is a drug marketed by Nexus Pharms and is included in one NDA. It is available from one supplier. There are four patents… The post New patent for Nexus Pharms drug EMERPHED appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharmafile

APRIL 19, 2023

Published date: 19/04/2023 Summary: 83% use email, portals, and paper to exchange information with study partners, slowing study execution and increasing risk of non-compliance BARCELONA, Spain — 19 Apr. 2023 — Veeva Systems (NYSE: VEEV) today released its first-ever report examining global trends in medtech clinical trials. According to the 2023 Veeva MedTech Clinical Benchmark Report , on-time data entry and data quality are the top challenges for medtech when working with clinical research si

Data Entry 52

Data Entry 52